| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The nitrogen-containing bisphosphonate, zoledronic acid, increases mineralisation of human bone-derived cells in vitro. | Bone | 2004 | 1.06 |
| 2 | Hypoxia-inducible factor-2 is a novel regulator of aberrant CXCL12 expression in multiple myeloma plasma cells. | Haematologica | 2009 | 0.97 |
| 3 | The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). | J Bone Miner Res | 2004 | 0.96 |
| 4 | Methylation of KLF5 contributes to reduced expression in acute myeloid leukaemia and is associated with poor overall survival. | Br J Haematol | 2013 | 0.79 |
| 5 | Outcomes of lymphoma in South Australia, 1977-2007. | Med J Aust | 2012 | 0.75 |
| 6 | Predicting Perioperative Transfusion in Elective Hip and Knee Arthroplasty: A Validated Predictive Model. | Anesthesiology | 2017 | 0.75 |